Alpha-interferon therapy for essential thrombocythaemia
- PMID: 2898699
- DOI: 10.1016/s0140-6736(88)90005-0
Alpha-interferon therapy for essential thrombocythaemia
Abstract
18 patients with symptomatic essential thrombocythaemia were treated with recombinant alpha interferon (2a or 2b). Subcutaneous dosage regimens, which were well-tolerated, selectively lowered the platelet count and relieved symptoms in all patients, whether previously treated or untreated. Recombinant alpha-interferon may offer a non-leukaemogenic alternative therapy for these patients.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
